Pediatric Hematology Oncology Research

UCLA provides a wide spectrum of research opportunities. The Howard Hughes Institute, Molecular Biology Institute, the Eli & Edythe Broad Institute for Stem Cell and Regenerative Medicine and California NanoSystems Institute are just a few examples of the infrastructure of basic research at the University that is available to our fellows.

The Division of Pediatric Hematology & Oncology at UCLA Mattel Children's Hospital has been a participant in Pediatric Clinical Trials for over 25 years. Greater than ninety percent of all pediatric oncology patients in this program are enrolled in at least one clinical trial. The majority of patients are in at least two trials.

The division is an active participant in several large pediatric cooperative groups. We have been funded members of the Children's Oncology Group (formerly CCSG and CCG) since 1976 and have participated in many of their research studies (clinical, epidemiologic and biologic) including the COBLT trial since its inception. We are a member and active participant of the Pediatric Bone Marrow Transplant Consortium (PBMTC), which is one of fourteen Clinical Core Centers in NHLBI Blood and Marrow Transplant Clinical Trials Network (CTN). We also participate in smaller consortiums that allow performance of smaller pilot studies.

Our pediatric oncology staff is actively involved in various cancer center committees and our faculty members continuously assess new protocols for their potential suitability and application to the pediatric oncology population. This includes membership on the ISPRC, Leukemia Research Study Group and other committees.

For more information, and for information of specific basic science research programs, please also browse the pages for individual faculty members.

We are deeply grateful to the St. Baldrick's Foundation for its continued support of our research and educational programs to find cures for childhood cancers